Current Biotech and Pharmaceutical News Today
Biotech Stocks: Celldex plunges; drug stock indexes climb
Celldex Therapeutics shares plunge in early trading after the biotech group announces that Pfizer Inc. was pulling out of a pact to develop Celldex's cancer vaccine CDX-110.
Fri, 03 Sep 2010 07:46:30 -0700
Pharmaceutical-Biotech Industry Maintains Balance With $2 Billion in Planned September Project Starts, an Industrial ...
SUGAR LAND, TX--(Marketwire - September 3, 2010) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- The million dollar question continues to be "... is the economy better, is it getting worse, or is it somewhere in between?" Theories abound, talking heads offer wildly varied opinions, while in regard to active capital investment, the facts can only be found in hard ...
Fri, 03 Sep 2010 02:45:19 -0700
Biotech Stocks: Orexigen soars on Takeda deal; Vivus gains
Shares of Orexigen jump on news that a Japanese pharmaceutical giant will commercialize Orexigen's new diet in North America, if and when it receives regulatory approval.
Thu, 02 Sep 2010 09:01:10 -0700
Sanofi offers $18.5 billion for Genzyme
French pharmaceutical firm Sanofi-Aventis is stepping up the pressure on U.S. biotech firm Genzyme, going public with an $18.5 billion cash offer and hinting it may consider a hostile takeover if Genzyme refuses to talk.
Thu, 02 Sep 2010 08:57:32 -0700
Volume Hunter: Diet Stocks Lift Biotech
The biotech sector was mixed on Thursday, but isolated stories sent select players soaring on notable volume spikes.
Thu, 02 Sep 2010 12:19:00 -0700
|
